Get alerts when HROW reports next quarter
Set up alerts — freeHarrow’s shares rose 10.5% after revenue reached a record $99.3 million, up 39% year over year, and the company reaffirmed full-year revenue guidance. The outlook calls for a substantial Q4 step-up, while management flagged gross margins as lower than expected.
See HROW alongside your other holdings
Add to your portfolio — freeTrack Harrow Health, Inc. in your portfolio with real-time analytics, dividend tracking, and more.
View HROW Analysis